Clinical Trial Update: Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating co-administration of Seretide 250 Diskus (fluticasone propionate/salmeterol) and Spiriva Capsule for Inhalation (tiotr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seretide 250 Diskus (fluticasone propionate/salmeterol)
• Spiriva Capsule for Inhalation (tiotropium)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2016-07-11